Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beatriz Mónico

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Pharmacy (Basel, Switzerland)|November 29, 2021
Dose Administration Aid Service in Community Pharmacies: Characterization and Impact AssessmentAndré Vicente, Beatriz Mónico, Mónica Lourenço, et al.
The Journal of Allergy and Clinical Immunology|September 12, 2018
Tobacco smoke as a risk factor for allergic sensitization in adults: Conclusions of a systematic review and meta-analysisBeatriz Mónico, Jorge M R Gama, M Ramiro Pastorinho, et al.
Allergy|September 9, 2020
β2-adrenergic agonists do not improve physical performance in healthy individualsAna Cardoso, Beatriz Mónico, Jorge M R Gama, et al.
Allergy|June 30, 2021
β2-adrenergic agonists and doping: Where do we stand?Olga Lourenço, Ana Cardoso, Beatriz Mónico, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Pharmacy (Basel, Switzerland)|November 29, 2021
Dose Administration Aid Service in Community Pharmacies: Characterization and Impact AssessmentAndré Vicente, Beatriz Mónico, Mónica Lourenço, et al.
The Journal of Allergy and Clinical Immunology|September 12, 2018
Tobacco smoke as a risk factor for allergic sensitization in adults: Conclusions of a systematic review and meta-analysisBeatriz Mónico, Jorge M R Gama, M Ramiro Pastorinho, et al.
Allergy|September 9, 2020
β2-adrenergic agonists do not improve physical performance in healthy individualsAna Cardoso, Beatriz Mónico, Jorge M R Gama, et al.
Allergy|June 30, 2021
β2-adrenergic agonists and doping: Where do we stand?Olga Lourenço, Ana Cardoso, Beatriz Mónico, et al.
Pageof 1